Reversible Henoch–Schönlein purpura complicating adalimumab therapy in a young patient with ulcerative colitis

2016 ◽  
Vol 48 ◽  
pp. e264
Author(s):  
M. Bramuzzo ◽  
S. Naviglio ◽  
S. Martelossi
2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Joseph J. LaConti ◽  
Jean A. Donet ◽  
Jeong Hee Cho-Vega ◽  
Daniel A. Sussman ◽  
Dana Ascherman ◽  
...  

Tumor necrosis factor-α(TNFα) inhibitor therapy has signified an important milestone in the fight against many rheumatological disorders and inflammatory bowel disease (IBD). Cutaneous adverse events caused by this class of medications are well known but relatively uncommon. Most reactions are mild and rarely warrant treatment withdrawal. Henoch-Schönlein purpura (HSP) is a disease with cutaneous vasculitis, arthritis, and gastrointestinal and renal involvement that is usually seen in children, though the worst complications are typically seen in adults. We present a case of HSP complicating adalimumab treatment in a patient with ulcerative colitis who had achieved endoscopic remission. We review similar cases reported in the literature and discuss the consequences of these autoimmune diseases.


2013 ◽  
Vol 7 (2) ◽  
pp. e69-e73 ◽  
Author(s):  
Guilherme Trudes de Oliveira ◽  
Sofia Simão Martins ◽  
Mariana Deboni ◽  
Patrícia Picciarelli ◽  
Lúcia Maria Arruda Campos ◽  
...  

2019 ◽  
Author(s):  
ELISA FERNANDES DE MELO ◽  
RAYLANE SHELLYDA DE ALMEIDA ANATE ◽  
VINICIUS VERLANGIERI SOUBIHE ◽  
NATÁLIA ENGLER RAVASIO ◽  
LAÍS HELENA BITTENCOURT RIBEIRO SOUBHIA ◽  
...  

2012 ◽  
Vol 6 (7) ◽  
pp. 796-799 ◽  
Author(s):  
Inês Marques ◽  
Ana Lagos ◽  
Jorge Reis ◽  
António Pinto ◽  
Beatriz Neves

Medicine ◽  
2018 ◽  
Vol 97 (35) ◽  
pp. e12036 ◽  
Author(s):  
Bin Lu ◽  
Li-Li Niu ◽  
Xi-Guang Xu ◽  
Shu-Lan Yao ◽  
Xing-You Tan

2015 ◽  
Vol 21 (19) ◽  
pp. 6082-6087 ◽  
Author(s):  
Yang Song ◽  
Yan-Hong Shi ◽  
Chong He ◽  
Chang-Qin Liu ◽  
Jun-Shan Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document